Several studies show that miR-454 functions as an oncogene in colorectal cancer [50], hepatocellular carcinoma [51], non-small cell lung cancer [52] and induce the oxaliplatin resistance in gastric carcinoma cells by targeting CYLD [53]. The gene discussed is CYLD; the disease is colorectal cancer.